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A B S T R A C T   
Pharmaceutically active compounds (PhACs) have been shown to accumulate in aquatic and riparian food-webs. 
Yet, our understanding of how temperature, a key environmental factor in nature, affects uptake, biotransfor-
mation, and the subsequent accumulation of PhACs in aquatic organisms is limited. In this study, we tested to 
what extent bioconcentration of an anxiolytic drugs (temazepam and oxazepam) is affected by two temperature 
regimes (10 and 20 ◦C) and how the temperature affects the temazepam biotransformation and subsequent 
accumulation of its metabolite (oxazepam) in aquatic organisms. We used European perch (Perca fluviatilis) and 
dragonfly larvae (Sympetrum sp.), which represent predator and prey species of high ecological relevance in food 
chains of boreal and temperate aquatic ecosystems. Experimental organisms were exposed to target pharma-
ceuticals at a range of concentrations (0.2–6 µg L− 1) to study concentration dependent differences in bio-
concentration and biotransformation. We found that the bioconcentration of temazepam in perch was 
significantly reduced at higher temperatures. Also, temperature had a strong effect on temazepam biotransfor-
mation in the fish, with the production and subsequent accumulation of its metabolite (oxazepam) being two-fold 
higher at 20 ◦C compared to 10 ◦C. In contrast, we found no temperature dependency for temazepam bio-
concentration in dragonfly larvae and no detectable biotransformation of the parent compound that would result 
in measurable concentrations of oxazepam in this organism. Our results highlight that while organisms may 
share the same aquatic ecosystem, their exposure to PhACs may change differently across temperature gradients 
in the environment.   
1. Introduction 
Pharmaceutically active compounds (PhACs) have been recognized 
as an important group of emerging contaminants in aquatic environ-
ments, with concentrations typically ranging from µg L− 1 levels close to 
point sources, down to low ng L− 1 levels in freshwater and marine 
ecosystems around the world (Brooks et al., 2005; Lopez-Serna et al., 
2012; Ruff et al., 2015; Alygizakis et al., 2016; Koba et al., 2018; Danner 
et al., 2019; Zhou et al., 2019). Consequently, a wide range of PhACs 
have been reported in the tissues of biota, including fish and macro-
invertebrates inhabiting contaminated water bodies (Brozinski et al., 
2013; Du et al., 2014; Grabicova et al., 2015; Huerta et al., 2018; 
Ondarza et al., 2019; Cerveny et al., 2021b), and even in mammals, 
birds, and spiders that feed on these aquatic species (Richards et al., 
2011; Bean et al., 2018; Richmond et al., 2018). Moreover, because the 
drug targets (i.e. receptors and enzymes) of PhACs are often highly 
evolutionarily conserved across species, pharmaceuticals have the po-
tential to exert similar effects in non-target organisms as they do in 
humans (Gunnarsson et al., 2008; Hutchinson et al., 2014). Indeed, the 
evidence for such pharmacological effects has grown rapidly over the 
last decade for certain classes of PhACs—e.g. antidepressants (Silva 
et al., 2015; Sehonova et al., 2018), anxiolytics (Brodin et al., 2013; 
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Saaristo et al., 2019; Cerveny et al., 2020), nonsteroidal anti- 
inflammatory drugs (Corcoran et al., 2010; Yokota et al., 2017), and 
endocrine-disrupting drugs such as steroidal estrogens (Corcoran et al., 
2010; Bertram et al., 2018). 
Pharmaceuticals are ultimately metabolized and/or excreted by 
human patients, and it is broadly assumed that the same physiological 
processes occur in non-target organisms (Burgos-Aceves et al., 2018). 
However, aquatic organisms occupy dynamic environments with 
physico-chemical properties that can vary rapidly, while data about 
toxicokinetics of pharmaceuticals are generally obtained from human 
patients or mammalian model systems and are thus based on stable 
conditions. Water characteristics such as pH (Nichols et al., 2015; Bitt-
ner et al., 2018; Scott et al., 2019), dissolved organic matter (Alsop and 
Wilson, 2019), oxygen saturation (Saari et al., 2020), and salinity (Scott 
et al., 2019) have been shown to significantly affect bioconcentration of 
certain PhACs in fish. While physico-chemical properties of water can 
vary greatly between different water bodies, knowledge about their role 
in the uptake, metabolic transformation, and excretion of pharmaceu-
ticals is still limited. 
Surprisingly, even less is known about whether adverse effects of 
PhAC exposure in non-target species could be mediated by temperature. 
This is cause for concern given that temperature is a fundamentally 
important environmental variable for ectothermic aquatic organisms, 
and is known to influence standard metabolic rate in fish (Clarke and 
Johnston, 1999; Killen et al., 2010; Ohlberger et al., 2012). Moreover, 
temperature affects the activity of detoxifying enzymes (e.g. cyto-
chromes P450) that are responsible for metabolic transformation of 
many environmental pollutants in fish, including PhACs (Ronisz et al., 
1999; Ricciardi et al., 2006; Louiz et al., 2017). The importance of 
temperature for aquatic organisms is well known and its role in toxicity, 
accumulation, and biotransformation of various other types of con-
taminants has previously been studied in fish—e.g. for polychlorinated 
biphenyls (Buckman et al., 2007; James and Kleinow, 2014), pesticides 
(Reinert et al., 1974; Edgren et al., 1979; Osterauer and Köhler, 2008; 
Hedrick-Hopper et al., 2015), and metals (Somero et al., 1977; Grasset 
et al., 2016; Dornelles Zebral et al., 2019). Despite this, few studies have 
included temperature as a variable when investigating biochemical and 
physiological responses (González-Mira et al., 2016; Cardoso et al., 
2019; Cox et al., 2019), uptake and elimination (Maulvault et al., 2018; 
Freitas et al., 2020), and behavioral responses (Cox et al., 2019; Saaristo 
et al., 2019; Wiles et al., 2020) to PhACs. 
The metabolites of many drugs also need to be considered as PhACs 
because of their biological activity and potential to exert pharmaco-
logical effects in non-target organisms (Celiz et al., 2009). Hence, studies 
that focus on biotransformation and subsequent accumulation of me-
tabolites in aquatic organisms are crucial to understanding the conse-
quences of pharmaceutical contamination of surface waters. As reported 
previously for both fish and macroinvertebrates, metabolites can accu-
mulate more than the parent drug, even without being present in water 
(Chen et al., 2017; Miller et al., 2017), and can reach tissue concentra-
tions predicted to exert pharmacological effects (Cerveny et al., 2021a). 
However, we are not aware of any work to date that has investigated 
whether the toxicokinetics of PhACs are affected by temperature in 
ectothermic aquatic organisms. 
Accordingly, the goal of the present work was to describe the role of 
temperature in the uptake and biotransformation of the benzodiazepine 
drug temazepam, and to characterize the accumulation of its metabolite, 
in two aquatic organisms. The selected fish (European perch, Perca flu-
viatilis) and insect (dragonfly larvae, Sympetrum sp.) model species 
inhabit freshwater ecosystems globally and are both seasonally exposed 
to temperatures typically ranging from 2 to 25 ◦C. Temazepam’s 
biotransformation product, oxazepam, is a highly prescribed benzodi-
azepine itself, and thus it represents a perfect example of a biologically 
active metabolite. Based on the documented effects of water tempera-
ture on fish metabolism (Clarke and Johnston, 1999; Killen et al., 2010; 
Ohlberger et al., 2012) and activity of detoxifying enzymes (Ronisz 
et al., 1999; Ricciardi et al., 2006; Louiz et al., 2017), we hypothesized 
that temperature would significantly affect the 1) bioconcentration of 
both studied drugs; and 2) biotransformation of temazepam in both 
experimental organisms. 
2. Materials and methods 
2.1. Experimental organisms 
Young-of-the-year European perch (n = 250) were collected from 
Lake Stocksjön (Umeå municipality, Sweden) in August 2019 and 
transported to the laboratory at Umeå University for acclimation. Fish 
were equally divided between two flow-through holding tanks (each 
filled with 800 L) that were continuously fed with non-chlorinated tap 
water and aerated. The tanks were equipped with artificial plants, pieces 
of plastic pipe, and stones providing refuge for the fish to reduce 
aggressive behavior. Stable housing conditions were maintained 
throughout the 40-day acclimation period (water temperature: 14 ◦C, 
oxygen saturation: >100%, pH: 7.8–8.2, light:dark regime of 12:12 h). 
Fish were fed with frozen chironomid larvae daily, and with live 
zooplankton collected from a fishless local pond every other day. Despite 
sufficient feeding, 10% mortality occurred during the acclimation 
period. This was most likely a result of cannibalistic behaviour, which is 
typical in this species (Persson et al., 2000; Mandiki et al., 2007). 
Dragonfly larvae (n = 480) were collected from two lakes 
(Nydalasjön and Brunnsjön) located in Umeå municipality, in July 2019. 
After being transported to the laboratory at Umeå University, larvae 
were randomly distributed into 16 glass aquaria (50 L each). Aquaria 
were filled with 10 L of aged tap water, with each also being enriched 
with 1 L of water from the lake of larvae origin. Organic debris from the 
lakes was also added to provide shelter for individual larvae and thereby 
reduce aggressive behavior. Larvae were allowed to acclimate for 48 h 
while being fed with live zooplankton. 
2.2. Exposure and sampling scenario 
2.2.1. Perch 
Bioconcentration with respect to temperature and drug concentra-
tion was studied for both temazepam and oxazepam. To accomplish this, 
fish were randomly allocated to 14 exposure treatments: control (i.e. 
unexposed, 0 µg L− 1), low oxazepam (0.2 µg L− 1), high oxazepam (2 µg 
L− 1), low temazepam (0.2 µg L− 1), high temazepam (2 µg L− 1), or a 
mixture of both compounds at either a low (0.2 µg L− 1 of each) or a high 
(2 µg L− 1 of each) concentration. Each treatment consists of 15 in-
dividuals. The concentrations of target drugs within this study were 
chosen based on the highest reported in wastewater effluents (Mazzitelli 
et al., 2018) and aquatic environments (Fick et al., 2017) in Europe. We 
included mixture treatments to increase the environmental relevance of 
the study as the two studied drugs have been reported to occur alongside 
in some European rivers (Fick et al., 2017). Each exposure scenario was 
carried out under two separate temperature regimes (10 or 20 ◦C) and 
treatments consisted of 15 individuals, except for the control in both 
temperature regimes, which each contained 12 individuals. Character-
istics of the experimental fish are provided in the Supplementary ma-
terial (Table S1). No significant differences in weight or total length 
were found between individuals allocated to different treatments 
(Supplementary material, Tables S2 and S3). Fish were exposed for 8 
days in an individual static exposure scenario using plastic containers 
(10 L) fitted with aeration, with each container being filled with 6 L of 
water. After being transferred from the flow-through housing tank into 
their respective exposure containers, fish were acclimated to either 
temperature regime by slowly increasing or decreasing the temperature 
(2 ◦C per day). When the target temperature was reached and stable, 
containers belonging to the oxazepam, temazepam, and mixture expo-
sure treatments were dosed with the respective amount of oxazepam or/ 
and temazepam stock solutions (both 2 mg L− 1, prepared by dissolving 
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the drug standard in ultrapure water). After the exposure period, each 
individual fish was removed from its exposure container, euthanized by 
overdose with tricaine methanesulfonate (MS-222) at 0.3 g L− 1, sprayed 
with ultrapure water to remove any excess external temazepam and/or 
oxazepam, dried with paper towel, and stored at − 18 ◦C until extraction 
and chemical analysis. Mortality occurred during the exposure period in 
both of the high-temperature mixture exposure treatments (one indi-
vidual of those exposed to 0.2 µg L− 1 and three individuals of those 
exposed to 2 µg L− 1). 
Water samples (n = 80) were collected on the first and last day of the 
exposure period from five randomly chosen exposure tanks per treat-
ment, and were analyzed to validate temazepam and oxazepam 
concentrations. 
2.2.2. Dragonfly larvae 
Bioconcentration in dragonfly larvae was investigated only for 
temazepam. This involved dragonflies being randomly allocated to one 
of six treatments: control (i.e. unexposed, 0 µg L− 1), low temazepam 
(0.5 µg L− 1), and high temazepam (5 µg L− 1), each of which was per-
formed under two separate temperature regimes (10 or 20 ◦C). Larvae (n 
= 20 per treatment) were exposed for 8 days in an individual static 
exposure scenario using plastic containers (8 × 8 × 8 cm) filled with 200 
mL of aged tap water. No differences in weight of individuals allocated 
to different treatments were found (Supplementary material, Tables S4 
and S5). After being allocated to their respective treatments, larvae were 
transferred to climate-controlled rooms and the temperature was slowly 
shifted towards the predetermined values (10 or 20 ◦C). When the 
temperature stabilized at the desired level, exposure containers assigned 
to each of the temazepam treatments were dosed with the respective 
amount of temazepam stock solution (1 mg L− 1, prepared by dissolving 
temazepam standard in ultrapure water). After the exposure period, 
each individual larva was euthanized by overdose with MS-222 at 0.3 g 
L− 1, sprayed with ultrapure water to remove any excess external 
temazepam, dried with paper towel, and stored at − 18 ◦C until extrac-
tion and analysis. Water samples (n = 30) were collected on the last day 
of exposure from five randomly chosen exposure containers per treat-
ment to validate the temazepam concentration. 
It should be noted that dragonfly larvae were assessed for the pur-
pose of another experiment, which explains slight differences between 
fish and dragonfly handling and exposure regimes. 
2.3. Chemical analyses 
The procedures followed to prepare water samples and extract biota 
samples for chemical analysis have been described in detail previously 
(see McCallum et al. (2019); Cerveny et al. (2020)). All concentrations 
measured in biota samples reported within this work are related to wet 
weight. 
For analysis of dragonfly larvae, whole individuals were extracted, 
each representing one sample. In the case of fish tissues, an equal portion 
of muscle tissue from fillet and whole brains of three individuals were 
pooled before extraction and thus each sample reflects average tissue 
concentration based on three fish. This approach was taken primarily 
because of the small brain size of juvenile fish, but also to reduce the cost 
of chemical analysis. Liquid chromatography–mass spectrometry 
(LC–MS)-grade acetonitrile, used for extraction of target analytes from 
biota samples, and methanol (LiChrosolv—hypergrade) were purchased 
from Merck (Darmstadt, Germany). Formic acid (Sigma-Aldrich, Stein-
heim, Germany) was used to prepare the 0.1% mobile phases for liquid 
chromatography. Temazepam (CAS 846-50-4) was purchased at LGC 
Standards (Teddington, UK). Oxazepam (CAS 604-75-1) and mass- 
labeled 2H5-oxazepam (CAS 65854-78-6) were purchased at Sigma- 
Aldrich (Steinheim, Germany). 
The method of liquid chromatography–tandem mass spectrometry 
(LC–MS/MS) that was used to analyse all biota samples has been 
described previously (McCallum et al., 2019). Water analysis was based 
on an online solid phase extraction system coupled with liquid 
chromatography-tandem mass spectrometry (SPE LC–MS/MS), also 
described in previous work (Khan et al., 2012). The LC system used for 
both biota and water samples consists of Ultimate 3000 pump (LPG- 
3400SD, Thermo Fisher Scientific, San Jose, CA) and a PAL HTC auto-
sampler (CTC Analytics AG, Zwingen, Switzerland). Target analytes 
were separated using a Hypersil GOLD column (2.1 mm × 50 mm, 3 μm, 
Thermo Fisher Scientific) and analysed with a TSQ Quantiva triple 
quadrupole mass spectrometer equipped with heated-electrospray ion-
isation (Thermo Fisher Scientific). Descriptions of the basic set-up of the 
electrospray ionisation interface and the gradient/flow of the mobile 
phase are presented in the Supplementary material (Tables S6–S8). 
Quantification of target compounds was based on an internal stan-
dard approach. A seven-point standard curve from 0.1 to 50 ng g− 1 
(biota samples) and an eight-point standard curve from 0.001 to 5 µg L− 1 
(water samples) were used to assess linearity and to derive an instru-
mental limit of quantification (LOQ). Peak area corresponding to the 
lowest point of the calibration curve that had a signal/noise ratio of at 
least 10 was then used for calculation of LOQs in individual samples. 
Quality assurance and quality control (QA/QC) of the analytical method 
was evaluated based on its linearity, LOQ, and measurement of solvent 
and water blank samples. 
2.4. Statistical analyses 
All statistical analyses were performed using Statistica software, 
version 13.2 (StatSoft Inc., USA). One-way analysis of variance 
(ANOVA) tests followed by a Tukey’s post-hoc tests were used to test for 
differences in concentrations of target analytes measured in samples of 
fish tissues and dragonfly larvae originating from different treatments. 
Observation of histograms supplemented with Shapiro-Wilk tests were 
used to assess whether the data were normally distributed. The con-
centrations obtained from analysis of fish tissues were log-transformed 
(ln x) to meet normality, while raw data were used for dragonfly 
larvae. To assess potential differences in weight and total length of 
experimental fish between the treatments, a non—parametric Krus-
kal—Wallis test was performed using the raw data as these did not fit 
normal distribution even after log transformation. Complete results of 
all statistical analyses related to measured concentrations of target 
compounds in fish and dragonfly larvae are provided in the Supple-
mentary material (Tables S9–S20). 
3. Results and discussion 
The analytical method performed excellently for both target com-
pounds. Linearity achieved by measurement of standard curves for 
water and tissue analysis was >0.999 and >0.998, respectively. The 
instrumental LOQs for measurement of water were set at 1 ng L− 1 for 
both compounds (the lowest point of the prepared standard curve), and 
the mean LOQs in real water samples were 0.9 and 1 ng L− 1 for tema-
zepam and oxazepam, respectively. In the case of tissue analysis, the 
instrumental LOQs were 1 and 0.5 ng g− 1 for temazepam and oxazepam, 
respectively, while mean LOQs in real samples ranged from 1.5 to 3.9 ng 
g− 1 and from 0.6 to 1.5 ng g− 1 for the two compounds. No oxazepam or 
temazepam concentrations above LOQ were measured in any of the 
blank samples. Low concentrations of oxazepam were detected in water 
from the temazepam treatments sampled at the end of the exposure 
period (Tables 1 and 2). Traces of oxazepam in these treatments were 
likely due to the biotransformation of the parent compound temazepam 
by the experimental organisms and subsequent excretion. However, we 
did not take any measures that would exclude initial contamination of 
the temazepam standard or its demethylation by microorganisms in the 
water during exposure. 
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3.1. Oxazepam and temazepam in fish 
The target compounds were not detected in any sample of water or 
fish tissue from the control treatments. Results of chemical analyses for 
the water and fish tissue samples originating from the low (0.2 µg L− 1) 
exposure treatments are presented in Table 1. Analogous results from 
the high (2 µg L− 1) exposure treatments are provided in the Supple-
mentary material (Table S21). Substantial bioconcentration and 
biotransformation of temazepam was observed in fish. Moreover, both 
the uptake of temazepam and the production of oxazepam via fish 
metabolism was greatly affected by temperature treatment. 
Specifically, when fish were exposed to 2 µg L− 1 of temazepam, we 
found significantly higher bioconcentration of temazepam in brain (p <
0.01) at the lower temperature treatment (Supplementary material, 
Fig. S1); hence, a finding confirming our first hypothesis. The first hy-
pothesis proved also valid for oxazepam, which in opposite to temaze-
pam bioconcentrated more at the higher temperature treatment. This 
trend was present in both of the sampled tissues (brain and muscle) and 
at both the low and high exposure levels for oxazepam (Figs. 1 and S1), 
but a statistically significant (p < 0.05) difference was only found in 
muscle of fish exposed to 2 µg L− 1. Moreover, that bioconcentration of 
oxazepam in perch increase with temperature makes it possible to rule 
out that decreasing water temperatures explain previous observations 
from aquatic ecosystems where the tissue:water ratio of this drug 
increased as the autumn progressed (Lagesson et al., 2016). 
When fish were exposed to the mixture of both compounds, oxaz-
epam bioconcentration became significantly (p < 0.05) different be-
tween the two temperature regimes, even at 0.2 µg L− 1. We also 
observed a positive effect of temperature on both the uptake of oxaz-
epam from the water and its production from temazepam via fish 
metabolism. In light of these results, we find that the effect of temper-
ature on internal concentrations of specific drugs is likely enhanced 
when uptake from water and accumulation resulting from metabolic 
transformation occur simultaneously—i.e. exposure to a complex 
mixture where both parent compounds and their metabolites are pre-
sent. This is important because such a scenario is expected in many 
aquatic environments affected by sewage treatment plant effluents, 
where fish are commonly exposed to multiple drugs contemporaneously. 
Temperature had a clear effect on the biotransformation of the 
parent compound (temazepam) into its metabolite (oxazepam) in the 
fish, i.e. a finding supporting our second hypothesis. Significantly more 
oxazepam (p < 0.01) was produced and accumulated in fish tissues 
when they were exposed to the parent drug at 20 ◦C compared to 10 ◦C 
(Fig. 1 and Fig. S1). Concentrations of oxazepam exceeded those of 
temazepam in perch maintained at 20 ◦C, which was not seen in fish 
exposed at 10 ◦C (Table 1 and Table S21). A similar phenomenon has 
previously been reported in zebrafish (Danio rerio) exposed to fluoxetine 
(Chen et al., 2017) and in channel catfish (Ictalurus punctatus) exposed to 
diazepam (Overturf et al., 2016). In both studies, the metabolites were 
measured in higher concentrations than their parent drugs in fish tissues 
without the metabolites being dosed in the water. The effect of tem-
perature was not investigated in those studies, but in both fish were 
maintained at 25 ◦C, which might indicate agreement with our findings. 
Nevertheless, without a deeper knowledge of potential species-specific 
differences in uptake and biotransformation, no conclusions can be 
drawn about the role of temperature in these studies. 
Interestingly, oxazepam accumulation that originated from meta-
bolic transformation (i.e. in fish that were exposed only to temazepam) 
was significantly higher (p < 0.01) than the bioconcentration of oxaz-
epam for individuals that were exposed to oxazepam itself. Indeed, this 
observation is entirely unique and brings new insights to what is known 
about the fate of pharmaceuticals in the aquatic environment. To date, 
the most important exposure pathway of pharmaceuticals in aquatic 
organisms is considered to be direct uptake from the water (i.e. respi-
ratory). But, based on our findings, metabolic transformation and the 
consequent accumulation of metabolites can result in a similar or even 
higher exposure compared to direct uptake. This is important because, if 
a metabolite is not thought of as being biologically active, or is even 
prescribed as a drug with the potential to induce pharmacological effects 
(as is the case for oxazepam), then evaluating the fate of pharmaceuti-
cals without knowledge of their pharmacokinetics in non-target species 
might underestimate their potential to induce adverse effects in natural 
systems. 
It is becoming more common in ecotoxicology to replace animal 
testing with modeling approaches for toxicity testing. However, there 
are still important knowledge gaps that need to be filled to properly 
parameterize these models. For instance, most of the models being used 
(e.g. fish plasma model) use data that are extrapolated from human or 
Table 1 
Measured concentrations of temazepam and oxazepam in water and in tissues of perch belonging to the low concentration (0.2 µg L− 1) exposure scenarios, and 
corresponding bioconcentration factors (BCF). See Supplementary Materials Table S21 for analogous results for the high concentration (2 µg L− 1) exposure treatments.  
Temperature/Treatment Water (µg L− 1) Fish tissues (ng g− 1) BCF (L kg− 1) 
n Oxazepam Temazepam n Oxazepam Temazepam 
∑
benzodiazepines muscle brain 
muscle brain muscle brain muscle brain 
10 ◦C Oxazepam 5 0.24 ± 0.071 <LOQ 5 3.1 ± 0.83 13 ± 2.9 <LOQ <LOQ 3.1 ± 0.83 13 ± 2.9 13 56 
Temazepam 5 <LOQ 0.21 ± 0.025 5 2.7 ± 0.64 11 ± 2.4 4.9 ± 1.4 21 ± 2.9 7.6 ± 1.04 32 ± 1.4 24 100 
Mix 5 0.26 ± 0.061 0.25 ± 0.037 5 7.8 ± 3.79 31 ± 11.5 6.3 ± 1.34 24 ± 9 13 ± 5.6 55 ± 16.7 NA NA 
20 ◦C Oxazepam 5 0.27 ± 0.064 <LOQ 5 5.3 ± 1.63 19 ± 4.8 <LOQ <LOQ 5.3 ± 1.63 19 ± 4.8 19 70 
Temazepam 5 <LOQ 0.26 ± 0.071 5 9.9 ± 1.84 35 ± 6.1 6.5 ± 2.39 22 ± 7.2 16 ± 4.1 57 ± 13.2 25 83 
Mix 5 0.25 ± 0.031 0.24 ± 0.034 5 14 ± 3.3 46 ± 7.4 5.1 ± 1.09 17 ± 3.8 16 ± 4.6 63 ± 10.9 NA NA  
Table 2 
Measured concentrations of temazepam and oxazepam in water and in whole-body homogenates of dragonfly larvae, and corresponding bioconcentration factors 
(BCF). Mean values and standard deviations are calculated using positive samples only.  
Temperature/treatment Water concentrations (µg L− 1) Dragonfly concentrations (ng g− 1) BCF (L kg− 1) 
n Mean ± SD (n positive) n Mean ± SD (n positive) 
temazepam oxazepam temazepam oxazepam temazepam 
10 ◦C Low concentration 5 0.62 ± 0.02 (5) <LOQ (0) 15 <LOQ (0) <LOQ (0) NA 
High concentration 5 6.30 ± 0.42 (5) 0.001 ± 0 (1) 15 2.8 ± 0.61 (10) <LOQ (0) 0.44 
20 ◦C Low concentration 5 0.63 ± 0.03 (5) <LOQ (0) 15 <LOQ (0) <LOQ (0) NA 
High concentration 5 6.10 ± 0.18 (5) 0.002 ± 0.0003 (5) 15 2.4 ± 0.47 (12) <LOQ (0) 0.39  
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mammalian pharmacology (Huggett et al., 2003; Brown et al., 2007). 
Our findings indicate that such extrapolation can be widely inappro-
priate, especially in the case of ectotherms. For instance, oxazepam is 
not considered to be an important metabolite of temazepam in humans. 
This is because, together with its conjugates, oxazepam accounts 
for<5% of the temazepam dose in treated patients (Schwarz, 1979; 
Locniskar and Greenblatt, 1990). And yet, in our recent work, oxazepam 
in the plasma of perch was shown to reach concentrations comparable to 
human therapeutic plasma concentrations (HTPC) reported by Schulz 
et al. (2012) after fish had been exposed to 1.3 µg L− 1 of temazepam 
(Cerveny et al., 2021a). Moreover, both human and veterinary phar-
maceuticals are designed to induce effects and then be metabolized and 
excreted at a certain limited body temperature range, but ectothermic 
aquatic organisms can exist at a range of temperatures from close to 0 ◦C 
to over 40 ◦C. Temperature can also vary throughout the year for in-
dividuals living in temperate regions, meaning that they can face 
different exposure (internal concentrations) in warm versus cold sea-
sons, even if they occupy the same locality with a theoretically stable 
pharmaceutical profile in the water column. However, it is well known 
that pharmaceutical pollution can also vary temporally (Lindholm-Lehto 
et al., 2016; Burns et al., 2018; Rehrl et al., 2020). This emphasizes the 
need to study the toxicokinetics of pharmaceuticals in non-target 
aquatic organisms under various temperature regimes that reflect their 
natural habitat and/or future climate change temperature scenarios. 
Temazepam and oxazepam are psychoactive pharmaceuticals 
belonging to the same class of benzodiazepines. Both can act as modu-
lators of gamma-aminobutyric acid (GABA) in the brain (Sieghart et al., 
2012) and thus combinatory (i.e. additive or synergistic) effects could be 
expected when organisms are exposed to these compounds simulta-
neously (Ågerstrand et al., 2015; Backhaus, 2016; Cerveny et al., 2020). 
Moreover, both drugs are being prescribed to treat human patients, and 
they are among the most frequently detected benzodiazepines in surface 
waters (Fick et al., 2017). For these reasons, the sum of temazepam and 
oxazepam concentrations was compared and statistically evaluated be-
tween treatments. The sum benzodiazepine concentration was higher at 
20 ◦C compared to 10 ◦C within each exposure scenario (i.e. oxazepam, 
temazepam, mixture), but a statistically significant difference (p < 0.05) 
was only found for the single exposure to temazepam (Fig. 1). Surpris-
ingly, exposure to only temazepam resulted in a similar sum concen-
tration of both of the benzodiazepines in fish tissues compared to fish 
that were exposed to both of the compounds simultaneously (when the 
same temperature treatment is considered). Hence, our results demon-
strate that ecotoxicology approaches that omit biologically active me-
tabolites from investigation are likely to underestimate risks related to 
pharmaceutical contamination in aquatic environments. 
Fig. 1. Temazepam, oxazepam, and their sum concentrations (Σ Benzodiazepines; i.e. temazepam + oxazepam) measured in muscle (1–3) and brain (4–6) of perch 
after 8 days of exposure to one of six treatments. These treatments comprise single or mixture low concentration (0.2 µg L− 1) exposure scenarios at each of two 
temperature levels (10 and 20 ◦C). Within each plot, letters (a–f) have been assigned to each treatment. Where significant differences (p < 0.05) were seen between 
treatments, those treatments are listed in parentheses. See Supplementary materials Fig. S1 for analogous results for the high concentration (2 µg L− 1) exposure 
treatment, and Tables S9–S14 for detailed results of statistical analyses. 
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3.2. Oxazepam and temazepam in dragonfly larvae 
Neither temazepam nor oxazepam were detected in the water or the 
larvae in the control treatment. Concentrations of both compounds 
measured in the water and the larvae from the temazepam exposure 
treatments are presented in Table 2 and discussed below. 
Compared to the fish, relatively low bioconcentration of temazepam 
was observed for dragonfly larvae. No quantifiable concentrations were 
measured in individuals exposed to low temazepam treatments, while 
the mean temazepam concentrations in larvae from the high exposure 
groups were <3 ng g− 1 (Table 2). No effect of temperature on temaze-
pam uptake was detected (Supplementary material, Table S22). In other 
words, our first hypothesis was not valid for the dragonfly larvae. 
Literature related to pharmacokinetics of human drugs in macro-
invertebrates is scarce, in general. In the work of Miller et al. (2017), 
bioconcentration of temazepam was studied in Gammarus pulex and a 
mean concentration of 38 ng g− 1 (dry weight, n = 3) was reached after 
48 h of exposure to 1 µg L− 1. Considering differences in temazepam 
exposure (their exposure was 6 times lower than in our work) and the 
fact that dry weight concentrations are typically higher by approxi-
mately a factor of four, there is still a great contrast when compared to 
our study. This indicates that there is a variability of temazepam bio-
concentration between different species of macroinvertebrates. 
No oxazepam was detected in any sample of dragonfly larvae, indi-
cating limited or no biotransformation of the parent compound. Again, a 
finding indicating that our second hypothesis, being valid for perch, was 
not valid for the dragonfly larvae. Nevertheless, considering the low 
bioconcentration of temazepam observed in the present study, and the 
low bioconcentration of oxazepam reported for the same species pre-
viously by Heynen et al. (2016), biotransformation may still have 
occurred without oxazepam having reached quantifiable levels in the 
larvae. Similarly to the bioconcentration of temazepam, its limited 
biotransformation into oxazepam observed in our work is also in 
disagreement with study of Miller et al. (2017) mentioned above. In that 
study, three different metabolites, nordiazepam, temazepam, and 
oxazepam, were identified in Gammarus pulex after exposure to 1 µg L− 1 
of diazepam (a benzodiazepine that can be biotransformed into both 
temazepam and oxazepam, as well as nordiazepam). 
After comparison with the very limited information that has been 
published so far, we conclude that there may be significant species- 
specific differences in uptake and biotransformation of pharmaceuti-
cals in aquatic macroinvertebrates. Clearly, this research field would 
benefit greatly from more information on the pharmacokinetics of 
pharmaceuticals in different macroinvertebrates species. Moreover, it 
would be fruitful to identify indicator species that could be preferen-
tially used to deepen our knowledge on the fate of pharmaceuticals in 
aquatic environments. 
4. Conclusions 
When evaluating risks related to the presence of PhACs in aquatic 
environments, prescribed pharmaceuticals (parent compounds), priori-
tized based on their occurrence in surface waters worldwide, are mostly 
considered. This approach is fairly reasonable based on the assumption 
that uptake from water represents the main exposure pathway for 
aquatic organisms. Nevertheless, as demonstrated by our work, certain 
PhACs can significantly accumulate in the body of aquatic organisms 
through biotransformation of the parent compound without being 
actually present in the water at all. Indeed, in the case of the compounds 
studied within this work, biotransformation was shown to be an 
important exposure pathway contributing significantly to direct uptake 
from the water. Therefore, pharmaceutical metabolites should be given 
more attention in future research as many can exert pharmacological 
effects comparable to parent drugs. Further, our findings underscore 
that using models to extrapolate data from mammalian pharmacology 
might not be an effective means for predicting pharmacokinetics in non- 
target species, especially for aquatic ectotherms. We also found that 
temperature affected the uptake, and especially the biotransformation, 
of temazepam to a great extent in fish. This observation is entirely novel 
and brings a new insight to our current understanding of the fate of 
PhACs in aquatic environments. Given that temperature represents one 
of the most dynamic parameters in surface waters, asymmetric effects of 
PhACs might be expected in aquatic organisms at both daily and sea-
sonal scales. Moreover, as ecosystems warm on a global scale due to 
human-induced climate change, it is more urgent than ever before to 
understand how temperature affects the toxicokinetics of pharmaceu-
tical contaminants in order to more effectively protect our aquatic 
ecosystems. 
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Cerveny, D., Grabic, R., Grabicová, K., Randák, T., Larsson, D.G.J., Johnson, A.C., 
Jürgens, M.D., Tysklind, M., Lindberg, R.H., Fick, J., 2021b. Neuroactive drugs and 
other pharmaceuticals found in blood plasma of wild European fish. Environ. Int. 
146. 
Chen, F., Gong, Z., Kelly, B.C., 2017. Bioaccumulation Behavior of Pharmaceuticals and 
Personal Care Products in Adult Zebrafish (Danio rerio): Influence of Physical- 
Chemical Properties and Biotransformation. Environ. Sci. Technol. 51, 
11085–11095. 
Clarke, A., Johnston, N.M., 1999. Scaling of metabolic rate with body mass and 
temperature in teleost fish. J. Anim. Ecol. 68, 893–905. 
Corcoran, J., Winter, M.J., Tyler, C.R., 2010. Pharmaceuticals in the aquatic 
environment: A critical review of the evidence for health effects in fish. Crit. Rev. 
Toxicol. 40, 287–304. 
Cox, M.K., Ward, J.L., Matsuura, M., Aing, R., Schoenfuss, H.L., Kohno, S., 2019. Estrone 
exposure interacts with temperature to alter predator evasion performance and 
systemic mRNA abundances. Sci. Total Environ. 692, 519–528. 
Danner, M.C., Robertson, A., Behrends, V., Reiss, J., 2019. Antibiotic pollution in surface 
fresh waters: Occurrence and effects. Sci. Total Environ. 664, 793–804. 
Dornelles Zebral, Y., Roza, M., da Silva Fonseca, J., Gomes Costa, P., Stürmer de 
Oliveira, C., Gubert Zocke, T., Lemos Dal Pizzol, J., Berteaux Robaldo, R., 
Bianchini, A., 2019. Waterborne copper is more toxic to the killifish Poecilia vivipara 
in elevated temperatures: Linking oxidative stress in the liver with reduced 
organismal thermal performance. Aquat. Toxicol. 209, 142–149. 
Du, B., Haddad, S.P., Luek, A., Scott, W.C., Saari, G.N., Kristofco, L.A., Connors, K.A., 
Rash, C., Rasmussen, J.B., Chambliss, C.K., Brooks, B.W., 2014. Bioaccumulation and 
trophic dilution of human pharmaceuticals across trophic positions of an effluent- 
dependent wadeable stream. Philosoph. Trans. Roy. Soc. B: Biol. Sci. 369. 
Edgren, M., Olsson, M., Renberg, L., 1979. Preliminary results on uptake and elimination 
at different temperatures of p, p’-DDT and two chlorobiphenyls in perch from 
brackish water. Ambio 8, 270–272. 
Fick, J., Brodin, T., Heynen, M., Klaminder, J., Jonsson, M., Grabicova, K., Randak, T., 
Grabic, R., Kodes, V., Slobodnik, J., Sweetman, A., Earnshaw, M., Caracciolo, A.B., 
Lettieri, T., Loos, R., 2017. Screening of benzodiazepines in thirty European rivers. 
Chemosphere 176, 324–332. 
Freitas, R., Silvestro, S., Pagano, M., Coppola, F., Meucci, V., Battaglia, F., Intorre, L., 
Soares, A.M.V.M., Pretti, C., Faggio, C., 2020. Impacts of salicylic acid in Mytilus 
galloprovincialis exposed to warming conditions. Environ. Toxicol. Pharmacol. 80, 
103448. 
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